IL-21可以选择性地增加抗原激活MAIT细胞的细胞毒性潜力
Laura E Wedlock1, Rajesh Lamichhane1, Meg C Webley1
1Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
European journal of immunology
|February 19, 2026
概括
干白素-21 (IL-21) 增强了粘膜关联不变T细胞 (MAIT) 的细胞毒性潜力. 这种细胞因子增强了MAIT细胞的B粒酶和穿孔素的表达,提高了它们消除受感染细胞的能力.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 微生物学 微生物学
背景情况:
- 粘膜关联不变T细胞 (MAIT) 是一种非常规的T细胞,通过MR1.1识别微生物代谢物.
- MAIT细胞的激活通过T细胞受体 (TCR) 参与或细胞因子信号传递 (IL-12/IL-18) 发生.
- 激活后,MAIT细胞释放细胞毒性分子,如酶B和穿孔素,以消除受感染的细胞,但细胞因子在调节这种细胞毒性的作用尚不清楚.
研究的目的:
- 调查细胞因特鲁金-21 (IL-21) 在调节MAIT细胞细胞毒性的特定作用.
- 确定IL-21是否影响细胞毒性分子的表达和MAIT细胞的杀伤能力.
主要方法:
- MAIT细胞通过TCR或IL-12/IL-18信号激活.
- 评估了IL-21原始化对MAIT细胞B粒酶和穿孔素表达的影响.
- 基于流细胞计的细胞毒性试验被用于测量MAIT细胞杀死标细胞 (5-OP-RU处理的B细胞系).
主要成果:
- IL-21显著增强了TCR或IL-12/IL-18激活MAIT细胞中的花粉酶B和穿孔素的表达.
- IL-21对MAIT细胞细胞因子产生的影响很小.
- 使用IL-21的原始治疗改善了MAIT细胞对细菌抗原呈现细胞的细胞毒性活性.
结论:
- IL-21作为一种共同刺激分子,可以选择性地增加MAIT细胞的细胞毒性潜力.
- 这一发现凸显了IL-21在增强MAIT细胞介导免疫力对抗微生物感染方面的新作用.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
T Cell Activation and Clonal Selection
16.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
T Cell Types and Functions
2.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.7K
Antigens Involved in Adaptive Immunity
1.6K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.6K
Cell-mediated Immune Responses
84.6K
Overview
84.6K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K


